Gastrointestinal Market - Global Outlook and Forecast 2023-2028

Report ID: 1031147 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Gastrointestinal Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Gastrointestinal Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Overall Market Size
    2.1 Global Gastrointestinal Market Size: 2021 VS 2028
    2.2 Global Gastrointestinal Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Gastrointestinal Players in Global Market
    3.2 Top Global Gastrointestinal Companies Ranked by Revenue
    3.3 Global Gastrointestinal Revenue by Companies
    3.4 Top 3 and Top 5 Gastrointestinal Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Gastrointestinal Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Gastrointestinal Players in Global Market
        3.6.1 List of Global Tier 1 Gastrointestinal Companies
        3.6.2 List of Global Tier 2 and Tier 3 Gastrointestinal Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Gastrointestinal Market Size Markets, 2021 & 2028
        4.1.2 Esophagus Diseases Drug
        4.1.3 Stomach Trouble Drug
        4.1.4 Colon Disease Drug
        4.1.5 Small Intestinal Diseases Drug
        4.1.6 Liver Disease Drug
        4.1.7 Pancreatic Disease Drug
        4.1.8 Gallbladder Disease Drug
        4.1.9 Other
    4.2 By Type - Global Gastrointestinal Revenue & Forecasts
        4.2.1 By Type - Global Gastrointestinal Revenue, 2017-2022
        4.2.2 By Type - Global Gastrointestinal Revenue, 2023-2028
        4.2.3 By Type - Global Gastrointestinal Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Gastrointestinal Market Size, 2021 & 2028
        5.1.2 Pharmaceutical And Biotechnology Companies
        5.1.3 Hospital
        5.1.4 Pharmacy
        5.1.5 Outpatient Surgical Centers And Clinics
        5.1.6 Academic And Research Organizations
        5.1.7 Other
    5.2 By Application - Global Gastrointestinal Revenue & Forecasts
        5.2.1 By Application - Global Gastrointestinal Revenue, 2017-2022
        5.2.2 By Application - Global Gastrointestinal Revenue, 2023-2028
        5.2.3 By Application - Global Gastrointestinal Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Gastrointestinal Market Size, 2021 & 2028
    6.2 By Region - Global Gastrointestinal Revenue & Forecasts
        6.2.1 By Region - Global Gastrointestinal Revenue, 2017-2022
        6.2.2 By Region - Global Gastrointestinal Revenue, 2023-2028
        6.2.3 By Region - Global Gastrointestinal Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Gastrointestinal Revenue, 2017-2028
        6.3.2 US Gastrointestinal Market Size, 2017-2028
        6.3.3 Canada Gastrointestinal Market Size, 2017-2028
        6.3.4 Mexico Gastrointestinal Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Gastrointestinal Revenue, 2017-2028
        6.4.2 Germany Gastrointestinal Market Size, 2017-2028
        6.4.3 France Gastrointestinal Market Size, 2017-2028
        6.4.4 U.K. Gastrointestinal Market Size, 2017-2028
        6.4.5 Italy Gastrointestinal Market Size, 2017-2028
        6.4.6 Russia Gastrointestinal Market Size, 2017-2028
        6.4.7 Nordic Countries Gastrointestinal Market Size, 2017-2028
        6.4.8 Benelux Gastrointestinal Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Gastrointestinal Revenue, 2017-2028
        6.5.2 China Gastrointestinal Market Size, 2017-2028
        6.5.3 Japan Gastrointestinal Market Size, 2017-2028
        6.5.4 South Korea Gastrointestinal Market Size, 2017-2028
        6.5.5 Southeast Asia Gastrointestinal Market Size, 2017-2028
        6.5.6 India Gastrointestinal Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Gastrointestinal Revenue, 2017-2028
        6.6.2 Brazil Gastrointestinal Market Size, 2017-2028
        6.6.3 Argentina Gastrointestinal Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Gastrointestinal Revenue, 2017-2028
        6.7.2 Turkey Gastrointestinal Market Size, 2017-2028
        6.7.3 Israel Gastrointestinal Market Size, 2017-2028
        6.7.4 Saudi Arabia Gastrointestinal Market Size, 2017-2028
        6.7.5 UAE Gastrointestinal Market Size, 2017-2028
7 Players Profiles
    7.1 Zhejiang Asia-pacific Pharmaceutical
        7.1.1 Zhejiang Asia-pacific Pharmaceutical Corporate Summary
        7.1.2 Zhejiang Asia-pacific Pharmaceutical Business Overview
        7.1.3 Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Major Product Offerings
        7.1.4 Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Revenue in Global Market (2017-2022)
        7.1.5 Zhejiang Asia-pacific Pharmaceutical Key News
    7.2 Yangtze Pharmaceutical Group
        7.2.1 Yangtze Pharmaceutical Group Corporate Summary
        7.2.2 Yangtze Pharmaceutical Group Business Overview
        7.2.3 Yangtze Pharmaceutical Group Gastrointestinal Major Product Offerings
        7.2.4 Yangtze Pharmaceutical Group Gastrointestinal Revenue in Global Market (2017-2022)
        7.2.5 Yangtze Pharmaceutical Group Key News
    7.3 Tillotts Pharma
        7.3.1 Tillotts Pharma Corporate Summary
        7.3.2 Tillotts Pharma Business Overview
        7.3.3 Tillotts Pharma Gastrointestinal Major Product Offerings
        7.3.4 Tillotts Pharma Gastrointestinal Revenue in Global Market (2017-2022)
        7.3.5 Tillotts Pharma Key News
    7.4 Solvay
        7.4.1 Solvay Corporate Summary
        7.4.2 Solvay Business Overview
        7.4.3 Solvay Gastrointestinal Major Product Offerings
        7.4.4 Solvay Gastrointestinal Revenue in Global Market (2017-2022)
        7.4.5 Solvay Key News
    7.5 Shire Pharmaceuticals
        7.5.1 Shire Pharmaceuticals Corporate Summary
        7.5.2 Shire Pharmaceuticals Business Overview
        7.5.3 Shire Pharmaceuticals Gastrointestinal Major Product Offerings
        7.5.4 Shire Pharmaceuticals Gastrointestinal Revenue in Global Market (2017-2022)
        7.5.5 Shire Pharmaceuticals Key News
    7.6 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
        7.6.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Summary
        7.6.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
        7.6.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Major Product Offerings
        7.6.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Revenue in Global Market (2017-2022)
        7.6.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Key News
    7.7 Shandong Luoxin Pharmaceutical Group
        7.7.1 Shandong Luoxin Pharmaceutical Group Corporate Summary
        7.7.2 Shandong Luoxin Pharmaceutical Group Business Overview
        7.7.3 Shandong Luoxin Pharmaceutical Group Gastrointestinal Major Product Offerings
        7.7.4 Shandong Luoxin Pharmaceutical Group Gastrointestinal Revenue in Global Market (2017-2022)
        7.7.5 Shandong Luoxin Pharmaceutical Group Key News
    7.8 Sanofi
        7.8.1 Sanofi Corporate Summary
        7.8.2 Sanofi Business Overview
        7.8.3 Sanofi Gastrointestinal Major Product Offerings
        7.8.4 Sanofi Gastrointestinal Revenue in Global Market (2017-2022)
        7.8.5 Sanofi Key News
    7.9 Roche
        7.9.1 Roche Corporate Summary
        7.9.2 Roche Business Overview
        7.9.3 Roche Gastrointestinal Major Product Offerings
        7.9.4 Roche Gastrointestinal Revenue in Global Market (2017-2022)
        7.9.5 Roche Key News
    7.10 Qilu Pharmaceutical Group
        7.10.1 Qilu Pharmaceutical Group Corporate Summary
        7.10.2 Qilu Pharmaceutical Group Business Overview
        7.10.3 Qilu Pharmaceutical Group Gastrointestinal Major Product Offerings
        7.10.4 Qilu Pharmaceutical Group Gastrointestinal Revenue in Global Market (2017-2022)
        7.10.5 Qilu Pharmaceutical Group Key News
    7.11 Pfizer
        7.11.1 Pfizer Corporate Summary
        7.11.2 Pfizer Business Overview
        7.11.3 Pfizer Gastrointestinal Major Product Offerings
        7.11.4 Pfizer Gastrointestinal Revenue in Global Market (2017-2022)
        7.11.5 Pfizer Key News
    7.12 Nycomed (Takeda)
        7.12.1 Nycomed (Takeda) Corporate Summary
        7.12.2 Nycomed (Takeda) Business Overview
        7.12.3 Nycomed (Takeda) Gastrointestinal Major Product Offerings
        7.12.4 Nycomed (Takeda) Gastrointestinal Revenue in Global Market (2017-2022)
        7.12.5 Nycomed (Takeda) Key News
    7.13 Novartis
        7.13.1 Novartis Corporate Summary
        7.13.2 Novartis Business Overview
        7.13.3 Novartis Gastrointestinal Major Product Offerings
        7.13.4 Novartis Gastrointestinal Revenue in Global Market (2017-2022)
        7.13.5 Novartis Key News
    7.14 Merck
        7.14.1 Merck Corporate Summary
        7.14.2 Merck Business Overview
        7.14.3 Merck Gastrointestinal Major Product Offerings
        7.14.4 Merck Gastrointestinal Revenue in Global Market (2017-2022)
        7.14.5 Merck Key News
    7.15 Livzon Pharmaceutical Group
        7.15.1 Livzon Pharmaceutical Group Corporate Summary
        7.15.2 Livzon Pharmaceutical Group Business Overview
        7.15.3 Livzon Pharmaceutical Group Gastrointestinal Major Product Offerings
        7.15.4 Livzon Pharmaceutical Group Gastrointestinal Revenue in Global Market (2017-2022)
        7.15.5 Livzon Pharmaceutical Group Key News
    7.16 Johnson & Johnson
        7.16.1 Johnson & Johnson Corporate Summary
        7.16.2 Johnson & Johnson Business Overview
        7.16.3 Johnson & Johnson Gastrointestinal Major Product Offerings
        7.16.4 Johnson & Johnson Gastrointestinal Revenue in Global Market (2017-2022)
        7.16.5 Johnson & Johnson Key News
    7.17 Jiangsu Aosaikang Pharmaceutical
        7.17.1 Jiangsu Aosaikang Pharmaceutical Corporate Summary
        7.17.2 Jiangsu Aosaikang Pharmaceutical Business Overview
        7.17.3 Jiangsu Aosaikang Pharmaceutical Gastrointestinal Major Product Offerings
        7.17.4 Jiangsu Aosaikang Pharmaceutical Gastrointestinal Revenue in Global Market (2017-2022)
        7.17.5 Jiangsu Aosaikang Pharmaceutical Key News
    7.18 Inner Mongolia Shuangqi Pharmaceutic
        7.18.1 Inner Mongolia Shuangqi Pharmaceutic Corporate Summary
        7.18.2 Inner Mongolia Shuangqi Pharmaceutic Business Overview
        7.18.3 Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Major Product Offerings
        7.18.4 Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Revenue in Global Market (2017-2022)
        7.18.5 Inner Mongolia Shuangqi Pharmaceutic Key News
    7.19 Huadong Medicine
        7.19.1 Huadong Medicine Corporate Summary
        7.19.2 Huadong Medicine Business Overview
        7.19.3 Huadong Medicine Gastrointestinal Major Product Offerings
        7.19.4 Huadong Medicine Gastrointestinal Revenue in Global Market (2017-2022)
        7.19.5 Huadong Medicine Key News
    7.20 GlaxoSmithKline
        7.20.1 GlaxoSmithKline Corporate Summary
        7.20.2 GlaxoSmithKline Business Overview
        7.20.3 GlaxoSmithKline Gastrointestinal Major Product Offerings
        7.20.4 GlaxoSmithKline Gastrointestinal Revenue in Global Market (2017-2022)
        7.20.5 GlaxoSmithKline Key News
    7.21 Eli Lilly
        7.21.1 Eli Lilly Corporate Summary
        7.21.2 Eli Lilly Business Overview
        7.21.3 Eli Lilly Gastrointestinal Major Product Offerings
        7.21.4 Eli Lilly Gastrointestinal Revenue in Global Market (2017-2022)
        7.21.5 Eli Lilly Key News
    7.22 CTTQ
        7.22.1 CTTQ Corporate Summary
        7.22.2 CTTQ Business Overview
        7.22.3 CTTQ Gastrointestinal Major Product Offerings
        7.22.4 CTTQ Gastrointestinal Revenue in Global Market (2017-2022)
        7.22.5 CTTQ Key News
    7.23 CSPC
        7.23.1 CSPC Corporate Summary
        7.23.2 CSPC Business Overview
        7.23.3 CSPC Gastrointestinal Major Product Offerings
        7.23.4 CSPC Gastrointestinal Revenue in Global Market (2017-2022)
        7.23.5 CSPC Key News
    7.24 Chengdu Tiantaishan Pharmaceutical
        7.24.1 Chengdu Tiantaishan Pharmaceutical Corporate Summary
        7.24.2 Chengdu Tiantaishan Pharmaceutical Business Overview
        7.24.3 Chengdu Tiantaishan Pharmaceutical Gastrointestinal Major Product Offerings
        7.24.4 Chengdu Tiantaishan Pharmaceutical Gastrointestinal Revenue in Global Market (2017-2022)
        7.24.5 Chengdu Tiantaishan Pharmaceutical Key News
    7.25 Beijing Kaiyin Technology
        7.25.1 Beijing Kaiyin Technology Corporate Summary
        7.25.2 Beijing Kaiyin Technology Business Overview
        7.25.3 Beijing Kaiyin Technology Gastrointestinal Major Product Offerings
        7.25.4 Beijing Kaiyin Technology Gastrointestinal Revenue in Global Market (2017-2022)
        7.25.5 Beijing Kaiyin Technology Key News
    7.26 AstraZeneca
        7.26.1 AstraZeneca Corporate Summary
        7.26.2 AstraZeneca Business Overview
        7.26.3 AstraZeneca Gastrointestinal Major Product Offerings
        7.26.4 AstraZeneca Gastrointestinal Revenue in Global Market (2017-2022)
        7.26.5 AstraZeneca Key News
    7.27 Amgen
        7.27.1 Amgen Corporate Summary
        7.27.2 Amgen Business Overview
        7.27.3 Amgen Gastrointestinal Major Product Offerings
        7.27.4 Amgen Gastrointestinal Revenue in Global Market (2017-2022)
        7.27.5 Amgen Key News
    7.28 Allergan
        7.28.1 Allergan Corporate Summary
        7.28.2 Allergan Business Overview
        7.28.3 Allergan Gastrointestinal Major Product Offerings
        7.28.4 Allergan Gastrointestinal Revenue in Global Market (2017-2022)
        7.28.5 Allergan Key News
    7.29 AbbVie
        7.29.1 AbbVie Corporate Summary
        7.29.2 AbbVie Business Overview
        7.29.3 AbbVie Gastrointestinal Major Product Offerings
        7.29.4 AbbVie Gastrointestinal Revenue in Global Market (2017-2022)
        7.29.5 AbbVie Key News
    7.30 Abbott
        7.30.1 Abbott Corporate Summary
        7.30.2 Abbott Business Overview
        7.30.3 Abbott Gastrointestinal Major Product Offerings
        7.30.4 Abbott Gastrointestinal Revenue in Global Market (2017-2022)
        7.30.5 Abbott Key News
    7.31 Fresenius
        7.31.1 Fresenius Corporate Summary
        7.31.2 Fresenius Business Overview
        7.31.3 Fresenius Gastrointestinal Major Product Offerings
        7.31.4 Fresenius Gastrointestinal Revenue in Global Market (2017-2022)
        7.31.5 Fresenius Key News
    7.32 Daewoong
        7.32.1 Daewoong Corporate Summary
        7.32.2 Daewoong Business Overview
        7.32.3 Daewoong Gastrointestinal Major Product Offerings
        7.32.4 Daewoong Gastrointestinal Revenue in Global Market (2017-2022)
        7.32.5 Daewoong Key News
    7.33 Dr.Falk Pharma
        7.33.1 Dr.Falk Pharma Corporate Summary
        7.33.2 Dr.Falk Pharma Business Overview
        7.33.3 Dr.Falk Pharma Gastrointestinal Major Product Offerings
        7.33.4 Dr.Falk Pharma Gastrointestinal Revenue in Global Market (2017-2022)
        7.33.5 Dr.Falk Pharma Key News
    7.34 Minophagen Pharmaceutical
        7.34.1 Minophagen Pharmaceutical Corporate Summary
        7.34.2 Minophagen Pharmaceutical Business Overview
        7.34.3 Minophagen Pharmaceutical Gastrointestinal Major Product Offerings
        7.34.4 Minophagen Pharmaceutical Gastrointestinal Revenue in Global Market (2017-2022)
        7.34.5 Minophagen Pharmaceutical Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Gastrointestinal Market Opportunities & Trends in Global Market
    Table 2. Gastrointestinal Market Drivers in Global Market
    Table 3. Gastrointestinal Market Restraints in Global Market
    Table 4. Key Players of Gastrointestinal in Global Market
    Table 5. Top Gastrointestinal Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Gastrointestinal Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Gastrointestinal Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Gastrointestinal Product Type
    Table 9. List of Global Tier 1 Gastrointestinal Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Gastrointestinal Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Gastrointestinal Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Gastrointestinal Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Gastrointestinal Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Gastrointestinal Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Gastrointestinal Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Gastrointestinal Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Gastrointestinal Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Gastrointestinal Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Gastrointestinal Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Gastrointestinal Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Gastrointestinal Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Gastrointestinal Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Gastrointestinal Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Gastrointestinal Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Gastrointestinal Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Gastrointestinal Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Gastrointestinal Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Gastrointestinal Revenue, (US$, Mn), 2023-2028
    Table 30. Zhejiang Asia-pacific Pharmaceutical Corporate Summary
    Table 31. Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Product Offerings
    Table 32. Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 33. Yangtze Pharmaceutical Group Corporate Summary
    Table 34. Yangtze Pharmaceutical Group Gastrointestinal Product Offerings
    Table 35. Yangtze Pharmaceutical Group Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 36. Tillotts Pharma Corporate Summary
    Table 37. Tillotts Pharma Gastrointestinal Product Offerings
    Table 38. Tillotts Pharma Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 39. Solvay Corporate Summary
    Table 40. Solvay Gastrointestinal Product Offerings
    Table 41. Solvay Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 42. Shire Pharmaceuticals Corporate Summary
    Table 43. Shire Pharmaceuticals Gastrointestinal Product Offerings
    Table 44. Shire Pharmaceuticals Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 45. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Summary
    Table 46. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Product Offerings
    Table 47. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 48. Shandong Luoxin Pharmaceutical Group Corporate Summary
    Table 49. Shandong Luoxin Pharmaceutical Group Gastrointestinal Product Offerings
    Table 50. Shandong Luoxin Pharmaceutical Group Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 51. Sanofi Corporate Summary
    Table 52. Sanofi Gastrointestinal Product Offerings
    Table 53. Sanofi Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 54. Roche Corporate Summary
    Table 55. Roche Gastrointestinal Product Offerings
    Table 56. Roche Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 57. Qilu Pharmaceutical Group Corporate Summary
    Table 58. Qilu Pharmaceutical Group Gastrointestinal Product Offerings
    Table 59. Qilu Pharmaceutical Group Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 60. Pfizer Corporate Summary
    Table 61. Pfizer Gastrointestinal Product Offerings
    Table 62. Pfizer Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 63. Nycomed (Takeda) Corporate Summary
    Table 64. Nycomed (Takeda) Gastrointestinal Product Offerings
    Table 65. Nycomed (Takeda) Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 66. Novartis Corporate Summary
    Table 67. Novartis Gastrointestinal Product Offerings
    Table 68. Novartis Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 69. Merck Corporate Summary
    Table 70. Merck Gastrointestinal Product Offerings
    Table 71. Merck Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 72. Livzon Pharmaceutical Group Corporate Summary
    Table 73. Livzon Pharmaceutical Group Gastrointestinal Product Offerings
    Table 74. Livzon Pharmaceutical Group Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 75. Johnson & Johnson Corporate Summary
    Table 76. Johnson & Johnson Gastrointestinal Product Offerings
    Table 77. Johnson & Johnson Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 78. Jiangsu Aosaikang Pharmaceutical Corporate Summary
    Table 79. Jiangsu Aosaikang Pharmaceutical Gastrointestinal Product Offerings
    Table 80. Jiangsu Aosaikang Pharmaceutical Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 81. Inner Mongolia Shuangqi Pharmaceutic Corporate Summary
    Table 82. Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Product Offerings
    Table 83. Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 84. Huadong Medicine Corporate Summary
    Table 85. Huadong Medicine Gastrointestinal Product Offerings
    Table 86. Huadong Medicine Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 87. GlaxoSmithKline Corporate Summary
    Table 88. GlaxoSmithKline Gastrointestinal Product Offerings
    Table 89. GlaxoSmithKline Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 90. Eli Lilly Corporate Summary
    Table 91. Eli Lilly Gastrointestinal Product Offerings
    Table 92. Eli Lilly Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 93. CTTQ Corporate Summary
    Table 94. CTTQ Gastrointestinal Product Offerings
    Table 95. CTTQ Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 96. CSPC Corporate Summary
    Table 97. CSPC Gastrointestinal Product Offerings
    Table 98. CSPC Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 99. Chengdu Tiantaishan Pharmaceutical Corporate Summary
    Table 100. Chengdu Tiantaishan Pharmaceutical Gastrointestinal Product Offerings
    Table 101. Chengdu Tiantaishan Pharmaceutical Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 102. Beijing Kaiyin Technology Corporate Summary
    Table 103. Beijing Kaiyin Technology Gastrointestinal Product Offerings
    Table 104. Beijing Kaiyin Technology Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 105. AstraZeneca Corporate Summary
    Table 106. AstraZeneca Gastrointestinal Product Offerings
    Table 107. AstraZeneca Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 108. Amgen Corporate Summary
    Table 109. Amgen Gastrointestinal Product Offerings
    Table 110. Amgen Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 111. Allergan Corporate Summary
    Table 112. Allergan Gastrointestinal Product Offerings
    Table 113. Allergan Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 114. AbbVie Corporate Summary
    Table 115. AbbVie Gastrointestinal Product Offerings
    Table 116. AbbVie Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 117. Abbott Corporate Summary
    Table 118. Abbott Gastrointestinal Product Offerings
    Table 119. Abbott Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 120. Fresenius Corporate Summary
    Table 121. Fresenius Gastrointestinal Product Offerings
    Table 122. Fresenius Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 123. Daewoong Corporate Summary
    Table 124. Daewoong Gastrointestinal Product Offerings
    Table 125. Daewoong Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 126. Dr.Falk Pharma Corporate Summary
    Table 127. Dr.Falk Pharma Gastrointestinal Product Offerings
    Table 128. Dr.Falk Pharma Gastrointestinal Revenue (US$, Mn), (2017-2022)
    Table 129. Minophagen Pharmaceutical Corporate Summary
    Table 130. Minophagen Pharmaceutical Gastrointestinal Product Offerings
    Table 131. Minophagen Pharmaceutical Gastrointestinal Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Gastrointestinal Segment by Type in 2021
    Figure 2. Gastrointestinal Segment by Application in 2021
    Figure 3. Global Gastrointestinal Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Gastrointestinal Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Gastrointestinal Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Gastrointestinal Revenue in 2021
    Figure 8. By Type - Global Gastrointestinal Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Gastrointestinal Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Gastrointestinal Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Gastrointestinal Revenue Market Share, 2017-2028
    Figure 12. US Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Gastrointestinal Revenue Market Share, 2017-2028
    Figure 16. Germany Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 17. France Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Gastrointestinal Revenue Market Share, 2017-2028
    Figure 24. China Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 28. India Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Gastrointestinal Revenue Market Share, 2017-2028
    Figure 30. Brazil Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Gastrointestinal Revenue Market Share, 2017-2028
    Figure 33. Turkey Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Gastrointestinal Revenue, (US$, Mn), 2017-2028
    Figure 37. Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Yangtze Pharmaceutical Group Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Tillotts Pharma Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Solvay Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Shire Pharmaceuticals Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Shandong Luoxin Pharmaceutical Group Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Sanofi Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Roche Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Qilu Pharmaceutical Group Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Pfizer Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Nycomed (Takeda) Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Novartis Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Merck Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Livzon Pharmaceutical Group Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Johnson & Johnson Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Jiangsu Aosaikang Pharmaceutical Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Huadong Medicine Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. GlaxoSmithKline Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Eli Lilly Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. CTTQ Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. CSPC Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 60. Chengdu Tiantaishan Pharmaceutical Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 61. Beijing Kaiyin Technology Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 62. AstraZeneca Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 63. Amgen Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 64. Allergan Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 65. AbbVie Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 66. Abbott Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 67. Fresenius Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 68. Daewoong Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 69. Dr.Falk Pharma Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 70. Minophagen Pharmaceutical Gastrointestinal Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
113
Frequently Asked Questions
Gastrointestinal Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports